US2022162603A1PendingUtilityA1
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation
Est. expiryNov 5, 2022(expired)· nominal 20-yr term from priority
Inventors:Charles AllersonBalkrishen BhatAnne B. EldrupMuthiah ManoharanRichard H. GriffeyBrenda F. BakerEric E. Swayze
C12N 2310/346C12N 15/1135C12N 2310/315C12N 2310/343C07H 21/00C12N 2310/341C07H 21/04C12N 2310/14C12N 2310/323A61K 48/005C12N 2310/321C12N 15/111C12N 2310/322C12N 2320/51C12N 15/113C07H 21/02C12N 2320/30
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides compositions comprising at least one oligomeric compound comprising an alternating motif and further include a region that is complementary to a nucleic acid target. The compositions are useful for targeting selected nucleic acid molecules and modulating the expression of one or more genes. In preferred embodiments the compositions of the present invention hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA. The present invention also provides methods for modulating gene expression.
Claims
exact text as granted — not AI-modified1 . An oligomeric compound comprising:
a plurality of nucleosides linked together in a sequence; said sequence comprising at least nucleosides of a first type (F) and nucleosides of a second type (S); said first and said second types of nucleosides differing in at least one aspect from one another in that they have different 2′-substituent groups; and when said 2′-substituent groups of said first and said second types of nucleosides are other than H or OH then said oligomeric compound includes at least two nucleosides of said first type and at least one nucleoside of said second type wherein said nucleosides of said first type and said nucleosides of said second type are located with respect to one another such that said sequence includes at least one FSF motif; or when the 2′-substituent group of one of said first or said second type of nucleoside is H or OH then said oligomeric compound includes at least three nucleosides of said first type and at least three nucleosides of said second type and said nucleosides of said first type and said nucleosides of said second type are located with respect to one another such that said sequence includes at least one FSFSFS motif.
2 .- 105 . (canceled)Join the waitlist — get patent alerts
Track US2022162603A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.